Showing results (1-10 of 123) with videos related to
Sort By:
Pageof 13
Expert Review of Clinical Immunology|July 18, 2024
CAR-T cell technologies that interact with the tumour microenvironment in solid tumoursChelsea Alice Taylor, Maya Glover, John MaherBiologics : Targets & Therapy|May 27, 2021
How Can We Engineer CAR T Cells to Overcome Resistance?Maya Glover, Stephanie Avraamides, John MaherHuman Vaccines & Immunotherapeutics|February 8, 2026
Harnessing the NKG2D immune surveillance pathway using engineered T-cells for the treatment of human diseaseMaya Glover, John Maher, David Marc DaviesOncotargets and Therapy|July 10, 2023
Chimeric Antigen Receptor (CAR) T-Cell Therapy for Patients with Lung Cancer: Current PerspectivesJohn MaherCurrent Gene Therapy|December 25, 2013
Clinical immunotherapy of B-cell malignancy using CD19-targeted CAR T-cellsJohn MaherISRN Oncology|January 11, 2013
Immunotherapy of malignant disease using chimeric antigen receptor engrafted T cellsJohn MaherFoot (Edinburgh, Scotland)|March 5, 2017
Patient reported outcomes six months following surgical treatment of end stage hallux rigidus in a community based podiatric surgery serviceAnthony John MaherTherapeutic Advances in Vaccines and Immunotherapy|June 12, 2020
CAR T-cell immunotherapy of B-cell malignancy: the story so farLeena Halim, John MaherMolecular Cancer Therapeutics|September 6, 2018
Strategies to Address Chimeric Antigen Receptor Tonic SignalingAdam Ajina, John MaherBiology|December 30, 2025
Prospects for Development and Commercialisation of Allogeneic CAR-Based Therapies for Autoimmune DiseaseMadeleine Osborne, John MaherPageof 13